Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:05.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial, while adding new drug information and a revision number.
    Difference
    11%
    Check dated 2025-04-16T10:12:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T04:59:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and last update date of March 19, 2025.
    Difference
    0.1%
    Check dated 2025-04-01T22:17:04.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the latest study results comparing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) and dolutegravir (DTG) + emtricitabine/tenofovir disoproxil fumarate (F/TDF) in treatment-naïve adults with HIV-1 and hepatitis B virus (HBV) co-infection, including new data on participant outcomes and study phases.
    Difference
    26%
    Check dated 2025-03-25T13:15:38.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:21:19.000Z thumbnail image

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.